Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01181544 · ClinicalTrials.gov registry record · NA
A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis
A NA study of Renal Failure Chronic Requiring Hemodialysis, sponsored by Vantive Health.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT01181544: Completed NA study of Renal Failure Chronic Requiring Hemodialysis, sponsored by Vantive Health.
NCT01181544 is a NA study of Renal Failure Chronic Requiring Hemodialysis that has completed, run by Vantive Health. The registered enrollment target is 5 participants, below the 55-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01181544, a NA study of Renal Failure Chronic Requiring Hemodialysis, has completed, sponsored by Vantive Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.
Primary Outcome
The objective is to titrate each patient's heparin dose to the level that achieves adequate anticoagulation for that patient as assessed by the change in blood compartment volume of the dialyzer from pre- to post-dialysis. The strategy that will be used is the Robbins-Monro stochastic approximation algorithm.
Conditions Studied
Interventions
- PROCEDURE Heparin dose titration
Study Locations (1)
Kentucky
- University of Louisville - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01181544 record still lists
NCT01181544 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 55-participant average among 3 other Renal Failure Chronic Requiring Hemodialysis trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Renal Failure Chronic Requiring Hemodialysis appearing as the primary indexed condition, and to 1 intervention - of which Heparin dose titration is the first listed.
NCT01181544 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT01181544 about?
NCT01181544 is a clinical study titled "A Pilot Study of a Heparin Dosing Algorithm for Hemodialysis". During hemodialysis treatments, patients receive heparin to prevent clotting. The purpose of this pilot study is to determine if the amount of heparin administered during a patient's hemodialysis can be individualized using an equation for heparin dose adjustment.
What is the current status of trial NCT01181544?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2011-03. Estimated completion is 2011-08.
What conditions does trial NCT01181544 study?
This clinical trial studies the following conditions: Renal Failure Chronic Requiring Hemodialysis.
What interventions are being tested in trial NCT01181544?
The interventions under investigation include: Heparin dose titration (PROCEDURE).
Who is sponsoring clinical trial NCT01181544?
This trial is sponsored by Vantive Health, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01181544 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Failure Chronic Requiring Hemodialysis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia